Acadia Healthcare Company Inc vs Pfizer Inc — how do they compare? Acadia Healthcare Company Inc trades at $30.82 (market cap $2.90B), while Pfizer Inc trades at $26.3 (market cap $151.73B). The key difference: Pfizer Inc is far larger — about 52.3× Acadia Healthcare Company Inc's market cap, and Pfizer Inc pays a 6.46% dividend while Acadia Healthcare Company Inc pays none. Which is the better fit depends on your goals.
| ACHC | PFE | |
|---|---|---|
Market Cap | $2.90B | $151.73B |
Sector | Health | Health |
52-Week High | $35.61 | $28.56 |
52-Week Low | $11.68 | $23.60 |
Enterprise Value | $5.29B | $203.22B |
Volume | — | 29,869,932 |
Dividend Yield | — | 6.46% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Pfizer (PFE) trades at $27.05, up 1.16% with a bullish technical signal and consistent earnings beats in recent quarters. Revenue remains stable around $62-63 billion, though net income is projected to decline in 2026. The stock shows strong profitability margins and a solid balance sheet, but faces headwinds from patent expirations and competitive pressures.
The outlook is mixed: valuation multiples appear reasonable, and analyst consensus leans hold with a $27.86 target. Key risks include execution on pipeline catalysts and margin compression. Upside depends on successful drug launches and cost management amid a challenging revenue environment.
Trailing returns across standard periods
Latest headlines on both assets
Acadia Healthcare is a leading provider of behavioral healthcare services across the US and Puerto Rico. It operates a network of psychiatric hospitals, residential treatment centers, and clinics for mental health and addiction recovery.
Read more on ACHC →Pfizer Inc. operates as a pharmaceutical company. The Company offers medicines, vaccines, medical devices, and consumer healthcare products for oncology, inflammation, cardiovascular, and other therapeutic areas. Pfizer serves customers worldwide.
Read more on PFE →